KCI Biotech (Suzhou) Inc, one of the SIP-based companies started and run by leading scientific and technological talents, put its new office building in Xinyang Industrial Park in SIP’s Yangcheng Digital Valley into use on Apr 24.
Founded in SIP in 2016, the company provides professional preclinical animal models in cardiovascular diseases, immune diseases, inflammatory diseases, metabolic diseases, urinary diseases, neuron diseases and oncology, and also conducts adjacency studies in PK/PD, preliminary toxicology, medical image, translational medicine and pathology. It has cooperated with more than 400 pharmaceutical R&D companies, and completed over 50 domestic and international investigational new drug application projects.
The new office building with upgraded research and experiment facilities will enable the company to enhance its R&D capability and expand its business coverage.
April 26, 2024
